Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Sandler

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|January 1, 1997
A single plan approach for differentially dosing sequential target volumesL H Marsh, R K Ten Haken, H M Sandler
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|January 1, 1992
A customized non-axial external beam technique for treatment of prostate carcinomasL H Marsh, R K Ten Haken, H M Sandler
Journal of Neuro-Oncology|January 1, 1994
Metastatic epidural spinal cord compression: current concepts and treatmentR Grant, S M Papadopoulos, H M Sandler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 1998
The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastomaN Fukunaga-Johnson, H M Sandler, R Marsh, et al.
Journal of Neurosurgery|October 11, 1991
Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapyB C Liang, A F Thornton, H M Sandler, et al.
Cancer|May 15, 1993
Myxopapillary ependymoma. Results of nucleolar organizing region stainingD A Ross, P E McKeever, H M Sandler, et al.
Neurosurgery|April 11, 1992
Spinal cord astrocytomas: results of therapyH M Sandler, S M Papadopoulos, A F Thornton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1992
Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapyH M Sandler, C Perez-Tamayo, R K Ten Haken, et al.
Urology|August 30, 2003
What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?K D DeWitt, H M Sandler, V Weinberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
The evolution of chemotherapy for the treatment of prostate cancerD I Quinn, H M Sandler, L G Horvath, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|January 1, 1997
A single plan approach for differentially dosing sequential target volumesL H Marsh, R K Ten Haken, H M Sandler
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|January 1, 1992
A customized non-axial external beam technique for treatment of prostate carcinomasL H Marsh, R K Ten Haken, H M Sandler
Journal of Neuro-Oncology|January 1, 1994
Metastatic epidural spinal cord compression: current concepts and treatmentR Grant, S M Papadopoulos, H M Sandler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 1998
The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastomaN Fukunaga-Johnson, H M Sandler, R Marsh, et al.
Journal of Neurosurgery|October 11, 1991
Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapyB C Liang, A F Thornton, H M Sandler, et al.
Cancer|May 15, 1993
Myxopapillary ependymoma. Results of nucleolar organizing region stainingD A Ross, P E McKeever, H M Sandler, et al.
Neurosurgery|April 11, 1992
Spinal cord astrocytomas: results of therapyH M Sandler, S M Papadopoulos, A F Thornton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1992
Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapyH M Sandler, C Perez-Tamayo, R K Ten Haken, et al.
Urology|August 30, 2003
What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?K D DeWitt, H M Sandler, V Weinberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
The evolution of chemotherapy for the treatment of prostate cancerD I Quinn, H M Sandler, L G Horvath, et al.
Pageof 8